UNSPSC 51151675: Umeclidinium

A drug administered via oral inhalation for use in adults to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disease COPD.

UNSPSC 51151675 Umeclidinium, a Commodity code, shows a fundamental mismatch between its nominal scope and recent state and local procurement activity. Umeclidinium is a specific active pharmaceutical ingredient (a long-acting muscarinic antagonist used in chronic obstructive pulmonary disease treatment), yet the five recent opportunities posted under this code span naloxone and drug deactivation systems (Seminole County, Florida), on-site pharmacy services (Hall County, Georgia), water-treatment chemicals (Orange County, California), direct-to-manufacturer prescription programs (Texas HHS Commission), and multi-source generic pharmaceuticals and OTC products (Minnesota MMCAP cooperative purchasing). None of these solicitations describe procurement of umeclidinium specifically. The code exhibits little relevant recent activity aligned to its stated substance.

The geographic spread across Florida, Georgia, California, Texas, and Minnesota reflects issuing bodies ranging from county health departments and local government family clinics to state health agencies and multistate cooperative purchasing alliances, but the diversity of products and services purchased—emergency medical supplies, wholesale pharmacy services, industrial water-treatment chemicals, and generic pharmaceutical sourcing—indicates either systematic misclassification of opportunities under this code or a data integrity issue in the state and local procurement system. No representative solicitation directly targets umeclidinium procurement. Firms evaluating this code should verify whether recent postings reflect actual market demand before committing business development resources to opportunities tagged under UNSPSC 51151675.